Suggested Topics within your search.
Suggested Topics within your search.
- Moral and ethical aspects 2
- ART / Digital 1
- Blogueurs vidéo 1
- Business English 1
- Business writing 1
- Childhood and youth 1
- Compagnons imaginaires 1
- Computer animation 1
- Cultural property 1
- Desertions 1
- Digital cinematography 1
- Disinformation 1
- Droit 1
- Economic policy 1
- English language 1
- Fake news 1
- Foreign economic relations 1
- Gender Identity 1
- Gender identity 1
- Historic preservation 1
- History 1
- Identity 1
- Identité 1
- Identité sexuelle 1
- Imaginary companions 1
- Intelligence service 1
- Management 1
- Mass media 1
- Media literacy 1
- Medical laws and legislation 1
-
61
Early warning systems for identifying severe maternal outcomes: findings from the WHO global maternal sepsis studyResearch in context
Published 2025-01-01“…Funding: UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Merck for Mothers, U.S. …”
Get full text
Article -
62
Outcomes among Mothers Who Gave Birth in the Health Facility: Does Birth Preparedness and Complication Readiness Have a Role?
Published 2019-01-01“…Giving childbirth is a natural reward for human beings to replace themselves to exist in the world. Despite all the efforts made to improve maternal health, maternal morbidity and mortality continue during childbirth. …”
Get full text
Article -
63
-
64
-
65
-
66
Strengthening National Immunization Technical Advisory Groups: Twelve Years of Progress (2012–2023)
Published 2025-01-01“…Methods: The data submitted annually by countries to the World Health Organization (WHO) via the WHO/UNICEF Joint Reporting Form (JRF) were analyzed, comparing the NITAG functionality criteria in 2012 and 2023. …”
Get full text
Article -
67
-
68
Adverse events of hepatic anti-fibrotic agents in phase 3 and above clinical trials: a descriptive analysis of the WHO-VigiAccess database
Published 2025-01-01“…This study assessed ADRs associated with anti-fibrotic agents as reported in the World Health Organization (WHO) VigiAccess database and compared the adverse reaction characteristics of these agents for optimizing therapeutic strategies.MethodsA detailed search was conducted on ClinicalTrial.gov to identify phase 3 or 4 clinical trials involving hepatic anti-fibrotic agents. …”
Get full text
Article -
69
-
70
Availability and accessibility of cytotoxic medicines in the WHO model list of essential medicines for childhood cancer in low and lower-middle- income countries: a systematic revi...
Published 2025-01-01“…Enablers and barriers were discussed based on the World Health Organization (WHO) health system building blocks. …”
Get full text
Article -
71
Integrating post-validation surveillance of lymphatic filariasis with the WHO STEPwise approach to non-communicable disease risk factor surveillance in Niue, a study protocol.
Published 2025-01-01“…After extensive efforts involving multiple rounds of Mass Drug Administration, Niue was validated by the World Health Organization (WHO) as having e4liminated LF as a public health problem in 2016. …”
Get full text
Article -
72
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
Published 2025-01-01“…BackgroundRadiation-induced changes following proton beam therapy in isocitrate dehydrogenase (IDH)-mutated diffuse central nervous system (CNS) World Health Organization (WHO) grade 2 and 3 gliomas are not well characterized. …”
Get full text
Article -
73
Achieving Hepatitis C Micro-Elimination in Chinese Injecting Drug Users: A Dynamic Network Modeling Study
Published 2024-12-01“…Abstract Introduction The World Health Organization (WHO) has established objectives for eradicating the hepatitis C virus (HCV). …”
Get full text
Article -
74
Case report: an unusual long-term evolution of a diffuse midline glioma, H3K27 altered
Published 2025-02-01“…Molecular neuropathology revealed the diagnosis of diffuse midline glioma with a H3K27M mutation WHO (World Health Organization) CNS (central nervous system) grade 4. …”
Get full text
Article -
75
-
76
-
77
-
78
-
79
WORLD EXPERIENCE OF GOVERNANCE REFORM
Published 2013-08-01“…In this regard, a number of experts, including experts from the World Bank, who prepared the materials for the Government Commission on lessons learned from reforms NPM, present restrained assessment of the reform results in various countries, noting their ambiguity and limited scope in relation to the objectives. …”
Get full text
Article -
80